Attached files

file filename
S-1 - FORM S-1 - ImmunoCellular Therapeutics, Ltd.d261236ds1.htm
EX-4.8 - FORM OF WARRANT TO PURCHASE COMMON STOCK - ImmunoCellular Therapeutics, Ltd.d261236dex48.htm
EX-23.1 - CONSENT OF MARCUM LLP - ImmunoCellular Therapeutics, Ltd.d261236dex231.htm

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the inclusion in this Registration Statement of ImmunoCellular Therapeutics, Ltd. on Form S-1 of our report dated March 31, 2010, with respect to our audit of the financial statements of ImmunoCellular Therapeutics, Ltd. as of December 31, 2009 and for the years ended December 31, 2009 and 2008, and for the period since February 25, 2004 (inception) to December 31, 2009, which report appears in the Prospectus that is part of this Registration Statement.

/s/ Stonefield Josephson, Inc.

Stonefield Josephson, Inc.

Los Angeles, California

November 29, 2011